Clinical Trials Browser

Phase 1/2 × Withdrawn × recombinant interferon alpha 2b-like protein × Clear all

NCT04418219 2025-04-29

Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer

Phase 1/2 Withdrawn

Breast Neoplasms